These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32019536)

  • 61. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New evidence on the HIV epidemic in Libya: why countries must implement prevention programs among people who inject drugs.
    Mirzoyan L; Berendes S; Jeffery C; Thomson J; Ben Othman H; Danon L; Turki AA; Saffialden R; Valadez JJ
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):577-83. PubMed ID: 23337363
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.
    Ishizaki A; Tran VT; Nguyen CH; Tanimoto T; Hoang HTT; Pham HV; Phan CTT; Bi X; Pham TV; Ichimura H
    PLoS One; 2017; 12(6):e0179616. PubMed ID: 28662105
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The prevalence of hepatitis B virus among HIV-positive patients at Kilimanjaro Christian Medical Centre Referral Hospital, Northern Tanzania.
    Kamenya T; Damian DJ; Ngocho JS; Philemon RN; Mahande MJ; Msuya SE
    Pan Afr Med J; 2017; 28():275. PubMed ID: 29881515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan.
    Ruiseñor-Escudero H; Wirtz AL; Berry M; Mfochive-Njindan I; Paikan F; Yousufi HA; Yadav RS; Burnham G; Vu A
    Drug Alcohol Depend; 2014 Oct; 143():127-33. PubMed ID: 25131717
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
    Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey.
    Alaei A; Alaei K; Waye K; Tracy M; Nalbandyan M; Mutlu E; Cetin MK
    J Viral Hepat; 2017 Jun; 24(6):496-505. PubMed ID: 27925346
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.
    Mumtaz GR; Weiss HA; Thomas SL; Riome S; Setayesh H; Riedner G; Semini I; Tawil O; Akala FA; Wilson D; Abu-Raddad LJ
    PLoS Med; 2014 Jun; 11(6):e1001663. PubMed ID: 24937136
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs - a single Centre retrospective cohort study in Denmark.
    Thønnings S; Jansåker F; Sundqvist C; Thudium RF; Nielsen SD; Knudsen JD
    BMC Infect Dis; 2020 Aug; 20(1):634. PubMed ID: 32847528
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
    Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
    Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis.
    Akbarzadeh V; Mumtaz GR; Awad SF; Weiss HA; Abu-Raddad LJ
    BMC Public Health; 2016 Dec; 16(1):1216. PubMed ID: 27912737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence of hepatitis B and anti-hepatitis C virus antibody among people who inject drugs in the Lebanese population.
    Rached AA; Nakhoul M; Richa C; Jreij A; Hanna PA; Ammar W
    East Mediterr Health J; 2020 Apr; 26(4):461-467. PubMed ID: 32338365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.